Zacks Research Has Pessimistic Outlook of UTHR Q3 Earnings
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities researchers at Zacks Research reduced their Q3 2025 earnings estimates for United Therapeutics in a research report issued on Tuesday, May 20th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings of $6.48 per share for the quarter, down from their […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities researchers at Zacks Research reduced their Q3 2025 earnings estimates for United Therapeutics in a research report issued on Tuesday, May 20th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings of $6.48 per share for the quarter, down from their […]
